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Abstract: 
A new series of propargylamine derivatives of 
mercaptobenzoxazole and oxazolo[4,5-b]pyridine-2-thiol 
derivatives 7a-7h were synthesized and evaluated for their 
antimicrobial activity. The synthesis of propargylamine 
derivatives has been achieved by the sequential reaction 
of 2-aminophenol/2-aminopyridin-3-ol with CS2, 
followed by alkylation and further reaction with 
secondary amines and formaldehyde undergoes a 
Mannich reaction at room temperature in the presence of 
CuI to afforded propargylamine derivatives. All the 
synthesized compounds were evaluated for their 
antimicrobial activity viz. E. coli, P. Aeruginosa, S. 
Aureus and S.Pyogenusand three pathogenic fungi viz. C. 
Albicans, A. niger and A. Clavatus and promising 
compounds were identified. 
Keywords: Mannich bases, Propagylamine 
derivatives, Benzo[d]oxazole-2-thiol, oxazolo[4,5-
b]pyridine-2-thiol,antibacterial activity, antifungal 
activity. 
1. Introduction:  
Multicomponent reactions are efficient and effective 
tool in organic synthesis for developing structurally 
diverse scaffold of biological interest due to their 
ability to form multiple bonds in a single step.1 In 
particular, Mannich reaction is one of the identity of 
multicomponent reaction which consist with three 
component reaction of aldehyde, amines and 
compounds having an acidic C-H bonding which 
afford corresponding products, generally called 
Mannich bases.2 Several compounds such as 
amines,3 amides,4 electron rich aromatic 
compounds5 and terminal alkynes can serve as 
substrate in Mannich reactions.  Mannich bases are 
found significant role in chemical and 
pharmaceutical industry.6 Terminal alkyne in 
Mannich reaction gives the corresponding 
propargylamines, some of the propargylamines are 
known to exhibit biological activities, such as 
substituted 1-aryl-3-aminopropynes shows sedative, 
antiulceration, hypnotic, antispasmodic, analgesic 
and anti-inflammatory activities.7 
Recently heterocyclic chemistry serve as key tool 
for the development of new bioactive molecules 
with wide range of pharmaceutical applications. In 
particular, benzene fused oxygen and nitrogen 
containing benzoxazoles and its derivatives display 
great devotion in the field of medicinal chemistry8 
due their significant biological properties such as 
melatonin receptor agonists,9 COX inhibitor,10 
anticancer agents,11 55-HT3 receptor antagonists12 
and HIV-1 reverse transcriptse inhibitors.13 
Interestingly, 2-mercaptobenzoxazole is a thiol 
derivative of  benzoxazole moiety which exists in 
tautomeric forms of thiol and thione.14 The 
extraordinary therapeutic properties of                   2-
mercaptobenzoxazole cause them as target 
compounds in organic synthesis and drug 
discovery.15 
In trust of medicinal chemistry, the finding focused 
on synthesis of oxazolopyridine-2-thiol derivatives 
as it encompass pyridine moiety and might offer 
some advantages over 2-mercaptobenzoxazole 
moiety. The favourable properties of pyridine 
fragment like Water solubility, site for protonation 
and salt formation could enhance the interaction 
with targeted protein via hydrogen bonding and may 
help in modulating the physical and biological 
property of the molecule. 
Therefore, it was projected that chemical entities 
with propargylamine with oxazolopyridine-2-thiol 
scaffold in one framework would result in improved 
biological activities. In view of these verdicts, we 
have attempted to synthesize propargylamine 
derivatives of mercapto benzoxazole and 
oxazolo[4,5-b]pyridine-2-thiol and evaluate its 
antimicrobial activity. Hence, here we disclose the 
synthesis of propargylamine derivative of 
mercaptobenzoxazole and oxazolo[4,5-b]pyridine-
2-thiol scaffolds and their anti-microbial activity.  
2. Experimental 
Materials and methods 
All chemicals and reagents were purchased from 
commercially available source and were used 
without further purification. Reactions were 
monitored by TLC, performed on silica gel glass 
plates containing 60 GF-254, and visualization on 
TLC was achieved by UV light or iodine indicator. 
Column chromatography was performed with 
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Merck 60–120 mesh silica gel. 1H and 13C spectra 
were recorded Bruker UXNMR/XWIN-NMR (300 
MHz) instruments. Chemical shifts (δ) are reported 
in ppm down field from internal TMS standard. ESI 
spectra were recorded on Micro mass, Quattro LC 
using ESI+ software with capillary voltage 3.98 kV 
and ESI mode positive ion trap detector. Melting 
points were determined by an open capillary tube 
melting point apparatus and were uncorrected.   
General procedures 
Preparation of benzooxazole/pyridine oxazole (3) 
2-aminophenol/3-hydroxy-2-aminopyridine 1 (4.5 
mmol), carbon disulphide 2 (4 ml) and potassium 
hydroxide (5.35 mmol) were taken in a 100ml round 
bottom flask and refluxed in 10ml of 95% ethanol 
for 7-8 hours. The reaction mixture was cooled to 
room temperature and concentrated. The 1M 
aqueous HCl solution was added to this concentrated 
reaction mixture. The product was filtered and 
washed with water (2 x 10 ml) and air dried. The 
dried product was recrystallized with ethanol. 
Preparation of 2-(prop-2-ynylthio)benzo[d] 
oxazole/2-(prop-2-ynylthio)oxazolo[4,5-b] 
pyridine (5) 
Benzo[d]oxazole-2-thiol/oxazolo[4,5-b]pyridine-2-
thiol 3 (3.0 mmol) was dissolved in dry N,N-
dimethylformamide (10 ml), and K2CO3 (6.0 mmol) 
was added and the reaction mixture was stirred for 
25 min at room temperature. The propargyl bromide 
4 (3.6 mmol) was added slowly drop wise to the 
above mixture over a period of 25 min and continued 
stirring for 4 h. after completion of reaction 
confirmed by TLC, The reaction was quenched with 
water and extracted with EtOAc (3 X 20 ml). The 
combined extracts were washed with water (3 X 25 
ml) and brine (20 ml). The organic layer was dried 
over Na2SO4, filtered, and evaporated under reduced 
pressure. Purification by silica gel chromatography 
(10 % ethyl acetate in hexane) gave the desired 
product.  
Synthesis of Mannich bases of 2-
mercaptobenzoxazole/oxazole pyridine-2-thiaol 
derivatives (7a-h) 
To a stirred solution of alkyne derivative 5 (1mmol) 
in tetrahydrofuran, 10 mol% CuI was added at room 
temperature. After stirring for 15 minutes, mixture 
of formaldehyde (1.5 equiv.) and secondary cyclic 
amine 6(1mmol) were added and stirring was 
continued for 4–6 h at the same temperature. After 
completion of reaction as indicated by TLC, the 
reaction mixture was quenched by saturated NH4Cl 
solution, diluted with water and extracted with ethyl 
acetate (2X15 ml).The combined organic layer was 
washed with brine solution, dried (Na2SO4), filtered 
and concentrated. The crude product was purified by 
column chromatography using ethyl acetate/n-
hexane gradients to afford Mannich base of 2-
mercaptobenzoxazole/oxazole pyridine-2-thiaol 
derivatives 7a-h as a pure product.  
2-((4-morpholinobut-2-yn-1-yl)thio)benzo[d] 
oxazole (7a) 
Yield 70%,  m.p. 70-730C, IR (KBr): ⱱ max cm-1 
2934, 2101, 1641, 1560, 1259, 1H NMR (300 MHz, 
CDCl3): δ 2.47 – 2.52 (m, 4H), 3.31 (s, 2H), 3.67 – 
3.72 (m, 6H), 7.40 – 7.48 (m, 2H), 7.60 – 7.69 (m, 
2H), 13C NMR(75 MHz, CDCl3): δ 22.98, 47.33, 
51.86, 66.61, 79.96, 81.47, 109.00, 120.63, 123.78, 
124.44, 141.50, MS for C15H16N2O2S (ESI): m/z 289 
[M+H]+.  
2-((4-(piperidin-1-yl)but-2-yn-1-yl)thio)benzo[d] 
oxazole (7b) 
Yield 63%,  m.p.78-800C, IR (KBr): ⱱ max cm-1 2930, 
2103, 1645, 1563, 1262, 1H NMR (300 MHz, 
CDCl3): δ 1.45 – 1.67 (m, 5H), 2.30 – 2.57 (m, 5H), 
3.27 (s, 2H), 3.55 (s, 2H), 6.89 – 7.00 (m, 2H), 7.24 
– 7.40 (m, 2H), 13C NMR(75 MHz, CDCl3): δ 22.54, 
23.67, 25.68, 47.74, 53.28, 79.31, 82.08, 110.28, 
120.63, 123.70, 124.43, 141.42, 150.11, MS for 
C16H18N2OS (ESI): m/z 286 [M+H]+.  
2-((4-(piperazin-1-yl)but-2-yn-1-yl)thio)benzo[d] 
oxazole (7c) 
Yield 74%,  m.p. 72-750C, IR (KBr): ⱱ max cm-1 
3258, 2960, 2116, 1659, 1514, 1249, 1H NMR (300 
MHz, CDCl3): δ 2.40 – 2.58 (m, 4H), 2.67 – 2.98 (m, 
4H), 3.12 (s, 2H), 3.29 (s, 2H), 4.46 (s, 1H), 7.33 – 
7.42 (m, 2H), 7.55 – 7.68 (m, 2H), 13C NMR(75 
MHz, CDCl3): δ 22.85, 47.17, 50.41, 52.23, 79.90, 
82.30, 110.40, 120.92, 123.82, 126.07, 141.60, 
150.41, MS for C15H17N3OS (ESI): m/z 288 [M+H]+.  
N-(4-(benzo[d]oxazol-2-ylthio)but-2-yn-1-yl)-N-
phenylaniline (7d) 
Yield 80%,  m.p.90-920C, IR (KBr): ⱱ max cm-1 2981, 
2119, 1721, 1513, 1273, 1H NMR (300 MHz, 
CDCl3): δ 3.84 (s, 2H), 4.79 (s, 2H), 6.69 – 6.88 (m, 
8H), 7.08 – 7.15 (m, 2H), 7.30 – 7.45 (m, 2H), 7.56 
– 7.69 (m, 2H), 13C NMR(75 MHz, CDCl3): δ 22.93, 
46.92, 79.95, 81.95, 110.30, 117.80, 121.35, 123.71, 
124.43, 128.85, MS for C23H18N2OS (ESI): m/z 371 
[M+H]+.  
2-((4-morpholinobut-2-yn-1-yl)thio)oxazolo[4,5-b] 
pyridine (7e) 
Yield 72%,  m.p. 78-800C, IR (KBr): ⱱ max cm-1 
2930, 2107, 1669, 1511, 1244, 1H NMR (300 MHz, 
CDCl3): δ 2.50 – 2.64 (m, 4H), 3.40 (s, 2H), 3.61 – 
3.73 (m, 6H), 7.25 – 7.32 (m, 1H), 7.44 – 7.53 (m, 
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1H), 8.15 – 8.24 (m, 1H), 13C NMR(75 MHz, 
CDCl3): δ 23.75, 48.65, 52.22, 66.85, 80.27, 81.84, 
119.45, 121.37, 148.53, 150.30, 156.31, MS for 
C14H15N3O2S (ESI): m/z 290 [M+H]+.  
2-((4-(piperidin-1-yl)but-2-yn-1-yl)thio)oxazolo 
[4,5-b]pyridine (7f) 
Yield 68%,  m.p. 109-1110C, IR (KBr): ⱱ max cm-1 
2930, 2106, 1640, 1561, 1260, 1H NMR (300 MHz, 
CDCl3): δ 1.48 – 1.76 (m, 5H), 2.35 – 2.58 (m, 5H), 
3.28 (s, 2H), 3.56 (s, 2H), 7.26 – 7.33 (m, 1H), 7.45 
– 7.53 (m, 1H), 8.17 – 8.26 (m, 1H), 13C NMR(75 
MHz, CDCl3): δ 22.68, 23.81, 25.82, 47.88, 53.42, 
79.45, 82.93, 120.77, 121.49, 148.43, 150.45, 
156.46, MS for C15H17N3OS (ESI): m/z 288 [M+H]+.  
2-((4-(piperazin-1-yl)but-2-yn-1-yl)thio)oxazolo 
[4,5-b]pyridine (7g) 
Yield 78%,  m.p. 106-1080C, IR (KBr): ⱱ max cm-1 
3269, 2920, 2106, 1664, 1511, 1296, 1H NMR (300 
MHz, CDCl3): δ 2.62 – 2.74 (m, 4H), 2.84 – 2.89 (m, 
4H), 3.16 (s, 2H), 3.31 (s, 2H), 4.40 (s, 1H), 7.24 – 
7.31 (m, 1H), 7.43 – 7.54 (m, 1H), 8.16 – 8.24 (m, 
1H), 13C NMR(75 MHz, CDCl3): δ 23.07, 
47.18,50.42, 52.25, 79.92, 82.31, 120.93, 121.49, 
148.76, 150.24, 156.40, MS for C14H16N4OS (ESI): 
m/z 289 [M+H]+.  
N-(4-(oxazolo[4,5-b]pyridin-2-ylthio)but-2-yn-1-
yl)-N-phenylaniline (7h) 
Yield 81%,  m.p. 103-1050C, IR (KBr): ⱱ max cm-1 
2934, 2117, 1592, 1440, 1236, 1H NMR (300 MHz, 
CDCl3): δ 3.90 (s, 2H), 4.80 (s, 2H), 6.70 – 6.89 (m, 
8H), 7.09 – 7.20 (m, 2H), 7.25 -7.32 (m, 1H), 7.42 -
7.51 (m, 1H), 8.18 – 8.23 (m, 1H), 13C NMR(75 
MHz, CDCl3): δ 23.13, 46.84, 80.22, 81.49, 120.57, 
121.32, 123.70, 128.83, 137.43, 147.64, 156.33, MS 
for C22H17N3OS (ESI): m/z 372 [M+H]+. 
3. Results and discussion 
3.1. Chemistry 
All the present propargylamine derivatives of 
mercaptobenzoxazole and oxazolo[4,5-b]pyridine-
2-thiol derivatives were synthesized through 
sequential reactions as presented in scheme 1 and 
scheme 2. Initially, we synthesized compounds 
benzo[d]oxazole-2-thiol/oxazolo[4,5-b]pyridine-2-
thiol 3 through reactions of 2-aminophenol/2-
aminopyridin-3-ol 1 with carbondisulphide 2 using 
potassium hydroxide in water under reflux 
condition, affording the respective product in good 
yield (Scheme 1).16,17 The structure of compound 3 
was confirmed on the basis of Mass spectrometry. It 
shows m/z value at 152 [M+H]+ for benzoxazole-2-
thiol and m/z 153 [M+H]+ for oxazolopyridine-2-
thiol. 
Scheme 1. Synthesis of propargyllated  benzoxazole/pyridinoxazole. 
Further compound 3 on reaction with propargyl 
bromide using two equivalent of inorganic base 
potassium carbonate in N,N-dimethyl formamide at 
ambient temperature resulted in the formation of  2-
(prop-2-ynylthio)oxazolo[4,5-b]pyridine/2-(prop-2-
ynylthio)benzo[d]oxazole 5. The propargylated 
compound of benzoxazole-2-thiol and oxazolo 
pyridine-2-thiol were confirmed by 1H NMR 
spectroscopy which shows signal at 4.09 and 4.17 
ppm for two proton of CH2 which consistent with 
compound 5.  Further multicomponent coupling 
reactions of alkyne compound 5, formaldehyde and 
various secondary amines in the presence of CuI (10 
mol%) in THF afford respective propargylamine 
derivatives 7a-h (Scheme 2).18 The results are 
summarized in Table 1. 
 
Scheme 2. Synthesis of propargylaminederivatives of 2-mercaptobenzoxazole/oxazolopridine-2-thiol. 
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All the propargylamine derivatives of 
mercaptobenzoxazole and oxazolo[4,5-b]pyridine-
2-thiol derivatives were characterized by 1H and 13C 
NMR spectroscopy which show carbon carbon triple 
bond formation at 79 and 82 ppm in the 13C NMR. 
All the synthesized propargylamine derivatives of 
mercaptobenzoxazole and oxazolo[4,5-b]pyridine-
2-thiol derivatives were evaluated for their 
antimicrobial activities. 
Table 1. Mannich bases of 2-mercaptobenzoxazole/oxazole pyridine-2-thiaol. 
 
 
 
 
3.2 Biological Activity 
3.2.1. Antimicrobial activity 
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The compounds 7a-h were screened for their 
antibacterial activity against E. coli, P. aeruginosa, 
S. aureus and S. pyogenus and antifungal activity 
against C. albicans, A. nigerand A. clavatusby Broth 
Dilution Method at different concentrations using 
DMSO as solvent.  The serial dilution was prepared 
in primary and secondary screening. In primary 
screening 1000 micro/ml, 500 micro/ml, and 250 
micro/ml concentrations of the synthesized drugs 
were taken. The synthesized drugs which were 
found active in this primary screening were further 
examined in a second set of dilution against all 
microorganisms. The drugs found active in primary 
screening were similarly diluted for secondary 
screening to obtain 200 micro/ml 100 micro/ml, 50 
micro/ml, 25 micro/ml, 12.5 micro/ml, and 6.250 
micro/ml concentrations. The control tube was 
instantly sub cultured [before inoculation] which 
does not contains antibiotic by spreading a loopful 
uniformly over a quarter of plate of medium 
appropriate for the development of the test organism 
and put for incubation at 37 0C overnight. The MIC 
of the control organism is read to check the accuracy 
of the drug concentrations. The lowest concentration 
inhibiting growth of the organism is recorded as the 
MIC. The zone of inhibition of the growth was 
measured. The activity was compared with the 
standard drugs. A commercial antibacterial 
Ampiciline, Chloramphenicol, and antifungal 
Griseofulvin were also tested under similar 
conditions for comparison. The results are presented 
in Tables 2 and 3. 
3.2.2. Antibacterial activity 
The minimum inhibitory concentrations (MIC) of 
various synthetic compounds were screened against 
two representative gram-negative organisms, viz. 
Escherichia coli (MTCC443) and Pseudomonas 
aeruginosa (MTCC441) and gram-positive 
microorganisms, viz. Staphylococcus 
aureus (MTCC96) and Streptococcus 
pyogenes (MTCC442). The assays were performed 
by broth dilution techniques. Standard antibacterial 
agents such as ampiciline, chloramphenicol and 
ciprofloxin were also screened under similar 
conditions for comparison. The minimum inhibitory 
concentration (MIC) values are display in Table 2. 
 
Table 2. Antibacterial activity of compounds 7a-7h 
 
Compound code 
MIC (microgram/ml) 
E. coli 
MTCC 443 
P. aeruginosa 
MTCC 441 
S. aureus 
MTCC 96 
S. pyogenus 
MTCC 442 
7a 200 100 500 500 
7b 100 125 200 250 
7c 62.5 100 100 250 
7d 62.5 200 100 125 
7e 200 250 62.5 100 
7f 250 250 200 250 
7g 200 200 250 200 
7h 62.5 100 125 100 
Ampiciline 100 -- 250 100 
Chloramphenicol 50 50 50 50 
MIC values are given in (µg/ml) = Minimum inhibitory concentration, i.e. the lowest concentration of drug 
which completely inhibit bacterial growth 
All compounds evaluated for their in vitro 
antibacterial activity. These results clearly indicate 
that compounds 7a–h displayed significant activity 
with a high degree of variation against Ampiciline. 
Based on the results, 75% of the compounds showed 
considerable high activity against gram-positive 
Staphylococcus aureus (MTCC96) bacterial strains. 
50% of the Compounds displayed significant 
activity against gram-negative Escherichia 
coli(MTCC443) bacterial strain and 25% of the 
compound showed good activity against gram 
positive Streptococcus pyogenes (MTCC442) while 
compounds are not showing sensitivity toward 
gram-negative Pseudomonas aeruginosa 
(MTCC441). Compounds 7b, 7c, 7d, 7e, 7f and 7h 
shows good activity against Staphylococcus 
aureus (MTCC96) than standard drug Ampiciline. 
Compound 7e display highest activity against S. 
aureus than other compounds. Compound 7b, 7c, 
7d, and 7h shows higher activity against gram-
negative E. coli bacterial strains than standard 
compound Ampiciline, among these compounds, 7c, 
7d and 7h compounds are most active among the 
series against E. coli.   Compounds 7e and 7h are 
only shows moderate activity against gram-positive 
S. pyogenus. Comparison with MIC value of tested 
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compound and standard drug, gram-positive 
bacterial strain show more sensitivity than gram-
negative bacterial strains. Among the synthesized 
series, compounds 7c, 7d, 7e, and 7h are found to be 
most active candidates as antibacterial agents. 
However, considering the MIC values of the 
standard molecule, the order of sensitivity of these 
bacterial strain towards propargylamine derivatives 
of mercapto benzoxazole and oxazolo[4,5-
b]pyridine-2-thiol derivatives is S. aureus>E. 
coli.>S. pyogenus>P. aeruginosa. 
 
3.2.3. Antifungal activity 
In vitro antifungal activity of the newly synthesized 
compounds were studied against the fungal strains, 
Candida albicans (MTCC 227), Aspergillus  niger 
(MTCC282) and Aspergillus clavatus (MTCC 1323) 
using Greseofulvin as a standard antifungal drugs as 
shown in Table 3. The antifungal screening data of 
compounds 7a-h revealed that compound 7b, 7c, 
and 7f shows higher antifungal activity against C. 
albicansantifungal strain than Greseofulvin as 
standard drug, whereas compounds 7d, 7g and 7h 
have equipotent activity with Greseofulvin standard 
drug against C. albicans antifungal strain. 
Compound 7b only show similar activity with 
standard drug against A. niger antifungal strains. 
Among entire synthesized series compounds 7b, 7c 
and 7f are found to be potent candidate as antifungal 
agents. Based on the results C. albicans strain 
displayed more sensitivity than other fungal strains 
with synthesized compounds. Considering the MIC 
values of the standard drug, the order of sensitivity 
of these fungal strain toward synthesized compound 
is C. albicans> A. niger>A. clavatus.  
According to the structure–activity relationship 
studies, the propargylamine derivatives of  pyridine-
2-thiaol exhibited comparatively greater 
antimicrobial activity than 2-mercaptobenzoxazole 
derivatives. In particular, compounds with 
substituent morpholine, piperazine and 
diphenylamine displayed enhanced antimicrobial 
activity. 
Table 3. Antifungal activity compound 7a-7h 
 
Compound code 
MIC (microgram/ml) 
 
C. albicans 
MTCC 227 
A. niger 
MTCC 282 
A. clavatus 
MTCC 1323 
7a 1000 250 250 
7b 250 100 >1000 
7c 250 500 500 
7d 500 1000 >1000 
7e 1000 500 250 
7f 250 500 500 
7g 500 1000 1000 
7h 500 1000 1000 
Greseofulvin 500 100 100 
MIC values are given in (µg/ml) = Minimum inhibitory concentration, i.e. the lowest concentration of drug which 
completely inhibit fungal growth 
 
Conclusion 
A series of propargylamine derivatives of 
mercaptobenzoxazole and oxazolo[4,5-b]pyridine-
2-thiol derivatives have been synthesized and 
screened for their antimicrobial activity. The results 
of antibacterial screening reveal that compounds 7c, 
7d, 7e and 7h showed good inhibition toward 
bacteria strain with Ampiciline drug and compounds 
7b, 7c, and 7f exhibited higher inhibition towards 
fungal strain with Greseofulvin drug. S. aureus 
antibacterial strain shows more sensitivity toward 
synthesized compound while in antifungal strain, C. 
albicansis found to be most sensitive. 
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